Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
Q2 2021 vs. Q1 2021
How the institutions holding Revolution Medicines, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 128 | 130 | +2 |
| Shares | 66.5M | 70.4M | +3.91M (+5.9%) |
| Value | $3.05B | $2.23B | −$815.7M (−26.8%) |
New holders (20)
Institutions that held Revolution Medicines, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blackstone Group Inc. | 416,629 | $13.2M | 0.03% |
| Point72 Asset Management, L.P. | 192,600 | $6.11M | 0.03% |
| Squarepoint Ops LLC | 145,886 | $4.63M | 0.03% |
| Tudor Investment Corp Et Al | 75,797 | $2.41M | 0.05% |
| Burrage Capital Management LLC | 50,000 | $1.59M | 1.59% |
| Marshall Wace, LLP | 35,031 | $1.11M | 0.01% |
| TD Asset Management Inc | 28,400 | $813.0K | 0.00% |
| AlphaCrest Capital Management LLC | 22,500 | $714.0K | 0.03% |
| Twinbeech Capital LP | 20,701 | $657.0K | 0.08% |
| Engineers Gate Manager LP | 18,099 | $574.0K | 0.04% |
| Martingale Asset Management L P | 8,000 | $254.0K | 0.00% |
| Bridgefront Capital, LLC | 7,733 | $245.0K | 0.09% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,999 | $159.0K | 0.00% |
| FORA Capital, LLC | 2,581 | $82.0K | 0.02% |
| Quantbot Technologies LP | 1,100 | $34.0K | 0.00% |
| Simplex Trading, LLC | 1,070 | $33.0K | 0.00% |
| Carolinas Wealth Consulting LLC | 1,023 | $32.0K | 0.01% |
| Ellevest, Inc. | 20 | $1.00K | 0.00% |
| State of Wyoming | 19 | $1.00K | 0.00% |
| Dark Forest Capital Management LP | 47 | $1.00K | 0.00% |
Sold out (18)
Institutions that held Revolution Medicines, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| TRV GP II, LLC | 1,909,317 | $87.6M |
| Driehaus Capital Management LLC | 205,788 | $9.44M |
| California Public Employees Retirement System | 75,902 | $3.48M |
| Maven Securities LTD | 34,012 | $1.51M |
| Ensign Peak Advisors, Inc | 32,413 | $1.49M |
| Laurion Capital Management LP | 10,000 | $459.0K |
| Copernicus Capital Management, LLC | 10,000 | $459.0K |
| SG Americas Securities, LLC | 9,813 | $450.0K |
| ExodusPoint Capital Management, LP | 8,662 | $397.0K |
| Athanor Capital, LP | 8,107 | $372.0K |
| Jane Street Group, LLC | 7,122 | $327.0K |
| Moloney Securities Asset Management, LLC | 4,500 | $206.0K |
| Royal Bank of Canada | 2,994 | $137.0K |
| Pacer Advisors, Inc. | 1,630 | $75.0K |
| Bank of Montreal | 1,593 | $72.0K |
| Eaton Vance Management | 126 | $6.00K |
| Steward Partners Investment Advisory, LLC | 125 | $5.74K |
| Sargent Bickham Lagudis LLC | 100 | $5.00K |